|
| Press Releases |
|
 |
|
| Wednesday, May 28, 2025 |
|
|
Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully |
| The fifth Asia Summit on Global Health (ASGH) and the 16th Hong Kong International Medical and Healthcare Fair (Medical Fair), both organised by the Hong Kong Trade Development Council (HKTDC), have drawn to a successful close. As flagship events of International Healthcare Week (IHW), both ASGH and the Medical Fair brought global healthcare stakeholders together, including government officials and organisations, research pioneers, investors, and business leaders. more info >> |
|
| Tuesday, April 30, 2024 |
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
| BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
| Thursday, October 5, 2023 |
|
|
Electronics Asia Conference 2023 to Highlight IoT, AI/ML, Automotive, and Wireless Developments Driving Semiconductor Industry Growth in Asia |
| Following the huge success of its inaugural edition, the Electronics Asia Conference (EAC), a virtual conference and exhibition organized by AspenCore, the publisher of EE Times Asia, EE Times India, and EDN Asia, is set to take place from October 17 to 19, 2023. more info >> |
|
| Tuesday, April 4, 2023 |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
| Monday, September 12, 2022 |
|
|
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma |
| Eisai and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) today announced the first presentation of results from the final analysis of the Phase 3 LEAP-002 trial investigating LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, plus KEYTRUDA. more info >> |
|
| Thursday, August 13, 2020 |
|
|
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma |
| QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable melanoma. more info >> |
|
| Tuesday, September 29, 2009 |
|
|
Next Generation Technologies to Boost Efficiency and Safety for Asia's Chemical Industries; Latest in Process Engineering, Controls, Instrumentation and Scientific Equipment at CIA2009 |
| CIA2009, Asia's leading process engineering, controls instrumentation and scientific equipment exhibition gathers the latest technologies and solutions that caters to industry demands to enhance product quality and expand production capacity while improving process safety and plant availability. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Champion REIT Presents 'Lupus Reimagined' Art Exhibition, Connecting Community Through Art 
Jun 6, 2025 22:35 HKT/SGT
|
|
|
International Consortium Rolls Out Major EV Battery Swapping Initiative in Tokyo
Jun 6, 2025 16:42 JST
|
|
|
Tredu.com Launches Global Platform to Revolutionize Trading Education
Jun 6, 2025 15:40 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES Receives 2025 Technology Award from Catalyst Manufacturers Association, Japan, for Development and Practical Application of Electrode Catalysts for PEM Water Electrolysis
Jun 6, 2025 11:00 JST
|
|
|
Fujitsu unveils Technology and Service Vision 2025: People-AI collaboration for a net positive future
Jun 6, 2025 10:44 JST
|
|
|
Latest Firewall Vulnerability Reinforces Need for Post-Breach Privileged Access Controls - TACACS.net Offers a Critical Layer
Jun 6, 2025 04:30 HKT/SGT
|
|
|
Naoris Protocol Expands into the Nordics with Strategic Consulting Hub in Oslo
Jun 5, 2025 21:00 HKT/SGT
|
|
|
PlayX Showcases AI-Powered Transparency and Fairness at SiGMA Asia 2025 in Manila
Jun 5, 2025 17:00 HKT/SGT
|
|
|
The Generation Essentials Group and Black Spade Acquisition II Co Complete Business Combination
Jun 5, 2025 11:33 HKT/SGT
|
|
|
Global Communities Unite at centralwOrld as Thailand Steps Forward on Global LGBTQ+ Stage with Central Pattana's Pride For All
Jun 5, 2025 08:30 HKT/SGT
|
|
|
TF International Facilitates Hong Kong's Successful Issuance of First Central Asian Sovereign Bond
Jun 4, 2025 22:28 HKT/SGT
|
|
|
Alpha Growth plc: Alpha Alternative Assets Fund Update ("AAAF")
Jun 4, 2025 15:00 JST
|
|
|
MHI Thermal Systems Receives A' Design Awards
Jun 4, 2025 14:10 JST
|
|
|
CBL International Limited Announces Share Repurchase Program
Jun 4, 2025 12:00 HKT/SGT
|
|
|
Orange completes successful trial of Fujitsu 1FINITY optical transport solution
Jun 4, 2025 12:58 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
